日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Spirituality and spiritual care in palliative and terminal illness: a systematic review and epistemic meta-analysis from physicians' hermeneutic and bioethical perspective

临终关怀和灵性关怀在姑息治疗中的应用：基于医生诠释学和生物伦理学视角的系统评价和认识论荟萃分析

期刊:BMC Palliative Care
影响因子:3
doi:10.1186/s12904-025-01916-x
Dorenbaum-Fastlicht, Arie; Castañeda, Ingrid; Guevara-López, Uría M; Altamirano-Bustamante, Myriam M
发表日期：2025
文献求助 收藏

Characterization of Fatigue in Primary Mitochondrial Myopathies: Findings From a Qualitative Interview Study

原发性线粒体肌病疲劳特征分析：一项定性访谈研究的发现

期刊:Neurology-Clinical Practice
影响因子:3.2
doi:10.1212/CPJ.0000000000200229
Karaa, Amel; Johnson, Nathan; Clarkson, Ian; Newman, Wendy; Dorenbaum, Alejandro; Cohen, Bruce H
线粒体
发表日期：2024
文献求助 收藏

Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study

马拉利西巴治疗成人原发性硬化性胆管炎的安全性、耐受性和有效性：开放标签试点研究

期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000153
Bowlus, Christopher L; Eksteen, Bertus; Cheung, Angela C; Thorburn, Douglas; Moylan, Cynthia A; Pockros, Paul J; Forman, Lisa M; Dorenbaum, Alejandro; Hirschfield, Gideon M; Kennedy, Ciara; Jaecklin, Thomas; McKibben, Andrew; Chien, Elaine; Baek, Marshall; Vig, Pamela; Levy, Cynthia
发表日期：2023
文献求助 收藏

Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study

Maralixibat 用于治疗 PFIC：一项开放标签的 II 期研究的长期 IBAT 抑制研究

期刊:Hepatology Communications
影响因子:4.6
doi:10.1002/hep4.1980
Loomes, Kathleen M; Squires, Robert H; Kelly, Deirdre; Rajwal, Sanjay; Soufi, Nisreen; Lachaux, Alain; Jankowska, Irena; Mack, Cara; Setchell, Kenneth D R; Karthikeyan, Palaniswamy; Kennedy, Ciara; Dorenbaum, Alejandro; Desai, Nirav K; Garner, Will; Jaecklin, Thomas; Vig, Pamela; Miethke, Alexander; Thompson, Richard J
发表日期：2022
文献求助 收藏

A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis

一项随机、对照、II期研究，评估马拉利昔巴治疗原发性胆汁性胆管炎相关瘙痒的疗效

期刊:Hepatology Communications
影响因子:4.6
doi:10.1002/hep4.1305
Mayo, Marlyn J; Pockros, Paul J; Jones, David; Bowlus, Christopher L; Levy, Cynthia; Patanwala, Imran; Bacon, Bruce; Luketic, Velimir; Vuppalanchi, Raj; Medendorp, Sharon; Dorenbaum, Alejandro; Kennedy, Ciara; Novak, Patricia; Gu, Joan; Apostol, George; Hirschfield, Gideon M
发表日期：2019
文献求助 收藏

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

在健康成人和 2 型糖尿病患者中，使用沃利西巴抑制顶端钠依赖性胆汁酸转运蛋白的安全性、耐受性和药效学：一项随机安慰剂对照试验

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-017-0736-0
Tiessen, Renger G; Kennedy, Ciara A; Keller, Bradley T; Levin, Nancy; Acevedo, Lisette; Gedulin, Bronislava; van Vliet, Andre A; Dorenbaum, Alejandro; Palmer, Melissa
糖尿病
代谢
发表日期：2018
文献求助 收藏

Chaperone-like therapy with tetrahydrobiopterin in clinical trials for phenylketonuria: is genotype a predictor of response?

在苯丙酮尿症的临床试验中，四氢生物蝶呤作为分子伴侣疗法：基因型是疗效的预测因素吗？

期刊:JIMD Reports
影响因子:1.8
doi:10.1007/8904_2011_96
Sarkissian, Christineh N; Gamez, Alejandra; Scott, Patrick; Dauvillier, Jerome; Dorenbaum, Alejandro; Scriver, Charles R; Stevens, Raymond C
发表日期：2012
文献求助 收藏

Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort

哮喘流行病学和自然史：结局和治疗方案（TENOR）观察队列研究中哮喘控制和哮喘急性发作的评估

期刊:
影响因子:
doi:10.1007/s13665-012-0025-x
Chipps, Bradley E; Zeiger, Robert S; Dorenbaum, Alejandro; Borish, Larry; Wenzel, Sally E; Miller, Dave P; Hayden, Mary Lou; Bleecker, Eugene R; Simons, F Estelle R; Szefler, Stanley J; Weiss, Scott T; Haselkorn, Tmirah
哮喘
发表日期：2012
文献求助 收藏